Results for
"[search-keyword]"
Sponsor content
339 result(s) found, displaying 21 to 30
-
Mar-2024Prescription medicine evaluationActive ingredient: sotatercept.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Feb-2024Prescription medicine evaluationActive ingredient: pembrolizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUVIA sitagliptin 50mg (as phosphate monohydrate) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUVIA sitagliptin 100mg (as phosphate monohydrate) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for XELEVIA sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack.
-
Jan-2024Prescription medicine evaluationActive ingredient: letermovir.